Transaction DateRecipientSharesTypePriceValue
15th September 2020Advisors Llc Perceptive2,911,764Open or private purchase$4.25$12,374,997.00
14th September 2020Advisors Llc Perceptive400,000Open or private purchase$40.00$16,000,000.00
14th September 2020Advisors Llc Perceptive1,800,000Open or private purchase$11.00$19,800,000.00
10th September 2020Advisors Llc Perceptive200,000Open or private purchase$11.24$2,248,000.00
9th July 2020Advisors Llc Perceptive3,200,000Open or private purchase$4.25$13,600,000.00
22nd June 2020Advisors Llc Perceptive1,750,000Open or private purchase$2.00$3,500,000.00
9th June 2020Advisors Llc Perceptive2,702,702Open or private purchase$1.85$4,999,998.70
5th May 2020Advisors Llc Perceptive76,172Payment by withholding$16.00$1,218,752.00
5th May 2020Advisors Llc Perceptive141,221Exercise of in-the-money or at-the-money derivatives securities (usually options)$8.63$1,218,737.23
5th May 2020Advisors Llc Perceptive339,604Exercise of in-the-money or at-the-money derivatives securities (usually options)$8.63$2,930,782.52
Kadmon Holdings
Kadmon Holdings logo

Kadmon Holdings, Inc. is a biopharmaceutical company. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir and Abacavir.

Ticker: KDMN
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1557142
Employees: 115
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags